key: cord-0848686-k8tqlheg
authors: Farzan, Nina; Vahabi, Sepideh; Foroghi ghomi, Seyed Yaser; Shirvani, Reza; Madani, Shima sadat Hashemi; Shakeri, Mansoureh; Araghi, Mahmood; Birjandi, Mehdi; Farzan, Behrooz
title: Evaluation of Invasive Ventilation (Intubation) Prognosis in Patients with Covid-19 Symptoms
date: 2020-11-16
journal: International journal of surgery open
DOI: 10.1016/j.ijso.2020.11.008
sha: 8bb3365ea675bd45860efd9f63a2ff42174a6ee0
doc_id: 848686
cord_uid: k8tqlheg

Background Coronavirus 2019 (COVID 19) has been reported as a pandemic by the world health organization. Increasing number of cases and associated mortality have demanded the need for clinical studies and researches. Objective The aim of this study is to evaluate intubation prognosis of the COVID 19 patients referred to Shahid Beheshti hospital in Qom city. Method COVID 19 patients referred to (XXX)were included in this study. Clinical sign and symptoms were recorded for each patient in a questionnaire. The diagnosis was made using real time polymerase chain reaction and chest CT scans. Lab findings from renal and liver function tests, blood count, c-reactive protein and electrolytes were also recorded. Shortness of breath was measured using oxygen saturation levels in these patients. The data was recorded in the electronic form and was analyzed using SPSS v21. Result Of 317 patients included in this study, the average age of COVID 19 patients were 59.71±16.46 years. The need of ventilation among the patients older than 50 years was significantly higher than younger patients, p=0.013. Smoking status, gender and drug addiction was not associated with the need of invasive mechanical ventilation, p=0.73, p=0.44 and p=0.76. Patients need invasive mechanical ventilation compared to those receiving non-invasive ventilation were significantly older, p=0.001. Conclusion The need of mechanical ventilation is significantly greater in advanced age COVID-19 patients.

First case of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing COVID 19 was reported in December 2019, in Wuhan, China and has spread broadly around the world.

According to the situation report 119 by the World Health Organization (WHO), 4,618,821 cases have been reported till May-18-2020, along with 311,847 deaths. The United State and European regions have been reported with the highest number of cases so far, 2,017,811 and 1,890,467 [1] .

The infection is known to have zoonotic origin associated with COVID 19 similar to severe acute respiratory syndrome (SARS)-coronavirus (80% nucleotide sequence identity) derived from bats. The virus is, therefore, evident to belong to orthocoronavirinae subfamily and betacoronavirus genus. The initial transmission of the virus was reported from the people who J o u r n a l P r e -p r o o f visited wet market in Wuhan City. Person-to-person transmission of the virus is believed by the close contact and aerosol droplets from sneezes and coughs [2] . Nonetheless, vertical transmission from pregnant mother to the fetus/child is not reported so far [3] .

The virus is known to cause respiratory tract infection similar to pneumonia. Commonly, patients are known to be presented with fever, dry cough and breathing difficulty. The mean period for the onset of the symptoms has been reported to be 14 days [2] . However, factors such as age, comorbidities such as diabetes, hypertension and coronary heart disease and increased D-dimer are characterized with poor prognosis [4] . Computed Tomography (CT) scan from the patients with COVID 19 pneumonia is seen to show ground glass opacity which progresses into craving patterns and consolidation [5] . Additionally, throat samples or sputum is used to detect viral RNA via real time polymerase chain reaction (RT-PCR). Chest CT is more sensitive for the screening of COVID 19 among patients with clinical signs and symptoms [6] .

The Islamic Republic of Iran is reported to be presented with 120,198 cases with 6,988 deaths according to the 119 th situation report by the WHO [1] . We hypotheses that advanced age, smoking, and male gender are likely to be associated with worse prognosis and corresponding need of mechanical ventilation. The aim of this study is to evaluate the requirement of invasive mechanical ventilation among COVID 19 patients presented in Qom's Shahid Beheshti hospital. The data was computerized and statistically analyzed using SPSS v21 software. The outcomes were reported in the form of frequency distribution tables and graphs. A paired t-test was conducted to compare oxygen levels before and after intubation.

Fisher's chi-square and precision tests were used to compare the rate of invasive mechanical ventilation in qualitative variables. Independent T-test was also used to compare quantitative variables with respect to invasive ventilation status. Comparison of clinical symptoms before and after invasive ventilation was also performed using paired T-test.

Statistical calculations were performed using SPSS 22 software. The significance level was considered to be 0.05.

This study was approved by the Research Ethics Board of (XXX).

As shown in the table 1, of the 317 patients 167 were male and 139 were female. The number of patients over the age of 50 years was 214 and 98 patients were below the age of 50.

The average age of patients was 59.71±16.46 years. 75% of patients are between the ages of 48

and 72, table2.

The rate of invasive mechanical ventilation was 11.8% for patients under 50 years of age and 24.9% for patients over 50 years of age. The Chi-Square test showed a significant relationship between age and the need of mechanical ventilation, therefore, the risk of need of mechanical ventilation among patients over the age of 50 was 2.5 time more, p=0.013, (table3)(figure1).

The rate of invasive mechanical ventilation was 29.9% in men and 19.3% in women. The Chi-Square test showed that there was no significant relationship between gender and the need of J o u r n a l P r e -p r o o f mechanical ventilation and the need of mechanical ventilation was same in men and women, p=0.44.

The rate of invasive mechanical ventilation was 23.3% for smokers and 20.7% for non-smokers.

The Chi-Square test showed no significant relationship between smoking status and the need of mechanical ventilation, p=0.733.

The rate of invasive mechanical ventilation was 93.7% among drug addicts and 94.5% among non-addicts. Fisher's exact test showed that there was no significant relationship between addiction status and the need of mechanical ventilation, p=0.762.

The mean age of patients with invasive mechanical and non-invasive ventilation was 65.82±15.307 and 58.24±16.35 years. The independent T-test showed that the age of patients needing invasive mechanical ventilation was significantly higher than patients receiving noninvasive ventilation (p = 0.001)(table4)(figure2).

Respiratory failure due to novel SARS-CoV-2 infection is associated with prolonged need of mechanical ventilation [7] . Studies have reported mortality rate of 25 and 57% among patients requiring intubation and mechanical ventilation [4, 8] . Data from studies conducted in China has revealed that older people with chronic comorbidities are likely to be presented with severe prognosis and have higher mortality rate than younger population. 80% of deaths reported in China are among the patients aged ≥ 60 years. Similar data has been provided through initial studies in the United States [9] . The outcomes of our study indicated that the advanced age among COVID 19 patients is associated with an increased in of mechanical ventilation. The need of invasive mechanical ventilation does not differ significantly with smoking status, drug addiction and gender.

A number of studies have concluded that smoking status might not significantly affect the risk of COVID 19 [10] [11] [12] . However, it is also indicated that smoking and chronic obstructive pulmonary disease is associated with increased expression of angiotensin converting enzyme (ACE) receptors in lungs, that can lead to worse prognosis [13] . Patients' hesitancy to admit their J o u r n a l P r e -p r o o f smoking and drug-addiction status due to cultural or family pressure could have led to these discrepancies in our findings.

A study by Liu W, Tao ZW, Wang Let al [14] including 78 COVID 19 patients reported that the severity of the disease is significantly associated with advanced age, history of smoking, fever, respiratory failure and increased serum albumin and c-reactive protein. A meta-analysis by Vardavas CI, Nikitara K [15] concluded that smokers are 2.4 times more likely to need ICU admission and mechanical ventilation. The outcomes of this meta-analysis are in parallel with our findings.

Goyal P, Choi JJ, Pinheiro LCet al [16] reported in their study from New York, the USA, that the need of mechanical ventilation is greater among male patients, those presented with atrial arrythmias and are undergoing renal replacement therapy. Additionally, obese patients and patients with elevated serum inflammatory markers also fall under this group. Our study reported that the need of mechanical ventilation did not differ among male and females. We did not provide the data regarding comorbidities and inflammatory markers. In a retrospective study enrolling 56 COVID 19 Liu K, Chen Y, Lin R, Han K [17] described that need of ventilation is significantly greater among elderly patients, aged ≥ 60 years. The results of our study reported that the need of mechanical ventilation is significantly greater among patients older than 50 years. Similarly, presented that mortality rates among COVID patients who received mechanical ventilation aged between 16-65 years and 65+ years were 76.4% and 97.2%.

Our study is limited to a relatively smaller sample size and need of invasive mechanical ventilation has not been presented in correlation with comorbidities and biochemical parameters.

A number of evidences from previous studies and our study imply that the load of mechanical ventilators is likely to increase in health care center where greater number of cases include elderly patients. Studies evaluating further patients' characteristics are therefore required to provide immediate and better treatment.

Our study indicated that advanced age is associated with an increased need of mechanical ventilation among COVID19 patients. The population of the patients studied here did not present a significant correlation with the need of ventilation with drugs, smoking and gender status.

Nonetheless, studies including vast amount of data are required to validate these outcomes.

J o u r n a l P r e -p r o o f Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.

Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Please specify the contribution of each author to the paper, eg study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in othe ways should be listed as contributors. 

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.

Coronavirus disease 2019 ( COVID-19) : situation report, 68

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Critical care crisis and some recommendations during the COVID-19 epidemic in China

Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical Characteristics of Coronavirus Disease 2019 in China

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

COVID-19 and smoking: A systematic review of the evidence

Clinical Characteristics of Covid-19 in

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Unique Identifying number or registration ID: N/A 3. Hyperlink to the registration

The authors deny any conflict of interest in any terms or by any means during the study.Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish Dr. Nina Farzan J o u r n a l P r e -p r o o f